Peyronnet, Benoit <br/><br/>
Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study.  [electronic resource] 

 -  Neurourology and urodynamics  03 2017 
 - 734-739 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1520-6777 
<br/><br/><label>Standard No.: </label>10.1002/nau.23009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Adult<br/>Botulinum Toxins, Type A--administration & dosage<br/>Case-Control Studies<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuromuscular Agents--administration & dosage<br/>Retrospective Studies<br/>Treatment Outcome<br/>Urinary Bladder, Neurogenic--drug therapy<br/>Urinary Bladder, Overactive--drug therapy<br/>Urodynamics--drug effects